Inhibition of α5 γ-Aminobutyric acid type A receptors restores recognition memory after general anesthesia
- PMID: 22383672
- DOI: 10.1213/ANE.0b013e31824720da
Inhibition of α5 γ-Aminobutyric acid type A receptors restores recognition memory after general anesthesia
Abstract
Background: General anesthetics cause cognitive deficits that persist much longer than would be expected on the basis of their pharmacokinetics. The cellular mechanisms underlying these postanesthetic cognitive deficits remain unknown. γ-Aminobutyric acid type A (GABA(A)) receptors are principal targets for most anesthetics. In particular, the α5GABA(A) receptor subtype has been implicated in acute memory blockade during anesthesia and memory deficits in the early postoperative period. We first sought to determine whether working memory and short-term recognition memory are impaired after isoflurane anesthesia. The second aim of the study was to determine whether memory deficits after isoflurane can be reversed by inhibiting α5GABA(A) receptors. We also sought to determine whether the expression of α5GABA(A) receptors is necessary for the development of memory dysfunction after isoflurane. Lastly, the effect of sevoflurane on memory was studied.
Methods: Wild-type and α5GABA(A) receptor null-mutant (Gabra5-/-) mice were treated with isoflurane (1.3%; 1 minimum alveolar concentration [MAC]) or sevoflurane (2.3%; 1 MAC) or vehicle gas for 1 hour. Memory performance was assessed with a novel object recognition task. Mice were trained on the recognition task either 24 hours or 72 hours after isoflurane anesthesia. Working memory and short-term memory were tested 1 minute and 1 hour after training, respectively. To determine whether inhibition of α5GABA(A) receptors reverses memory deficits, we treated a subset of mice with L-655,708 (0.35 mg/kg or 0.7 mg/kg) 23.5 hours after isoflurane and 30 minutes before behavioral training.
Results: Short-term memory was impaired in wild-type mice 24 hours after isoflurane as evidenced by a decrease in the discrimination ratio (control 0.66 ± 0.03 vs isoflurane 0.51 ± 0.03, P = 0.0005). In contrast, working memory was not impaired by isoflurane (control 0.68 ± 0.05 vs isoflurane 0.67 ± 0.04, P = 0.979). The deficit in short-term memory was fully reversed by L-655,708 (effect of isoflurane × L-655,708, F(2,102) = 3.59, P = 0.032; isoflurane 0.51 ± 0.03 vs isoflurane + L-655,708 at 0.35 mg/kg 0.67 ± 0.03, P < 0.05). By 72 hours, the deficits in short-term memory resolved spontaneously (control 0.65 ± 0.05 vs isoflurane 0.60 ± 0.04, P = 0.441). Gabra5-/- mice showed no short-term memory deficits 24 hours after isoflurane (effect of isoflurane F(1,47) = 0.375, P = 0.544). Sevoflurane also caused memory deficits 24 hours after anesthesia, as evidence by a reduction in the discrimination ratio (control 0.63 ± 0.02 vs sevoflurane 0.53 ± 0.03, P = 0.039).
Conclusions: Inhalational anesthetics cause deficits in anterograde recognition memory. This proof-of-concept study shows that α5GABA(A) receptors are necessary for the development of postanesthetic deficits in recognition memory and that these receptors can be targeted to restore memory even after the anesthetic has been eliminated.
Similar articles
-
Short-term memory impairment after isoflurane in mice is prevented by the α5 γ-aminobutyric acid type A receptor inverse agonist L-655,708.Anesthesiology. 2010 Nov;113(5):1061-71. doi: 10.1097/ALN.0b013e3181f56228. Anesthesiology. 2010. PMID: 20966663
-
Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade.Anesthesiology. 2009 Nov;111(5):1025-35. doi: 10.1097/ALN.0b013e3181bbc961. Anesthesiology. 2009. PMID: 19809285
-
Sustained increase in α5GABAA receptor function impairs memory after anesthesia.J Clin Invest. 2014 Dec;124(12):5437-41. doi: 10.1172/JCI76669. Epub 2014 Nov 3. J Clin Invest. 2014. PMID: 25365226 Free PMC article.
-
GABA(A) receptor subtypes underlying general anesthesia.Pharmacol Biochem Behav. 2008 Jul;90(1):105-12. doi: 10.1016/j.pbb.2007.12.011. Epub 2008 Jan 16. Pharmacol Biochem Behav. 2008. PMID: 18201756 Review.
-
Treating enhanced GABAergic inhibition in Down syndrome: use of GABA α5-selective inverse agonists.Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:218-27. doi: 10.1016/j.neubiorev.2013.12.008. Epub 2014 Jan 9. Neurosci Biobehav Rev. 2014. PMID: 24412222 Review.
Cited by
-
Proteomic Learning of Gamma-Aminobutyric Acid (GABA) Receptor-Mediated Anesthesia.J Chem Inf Model. 2025 Apr 14;65(7):3655-3668. doi: 10.1021/acs.jcim.5c00114. Epub 2025 Mar 17. J Chem Inf Model. 2025. PMID: 40094320 Free PMC article.
-
Recovery of consciousness and cognition after general anesthesia in humans.Elife. 2021 May 10;10:e59525. doi: 10.7554/eLife.59525. Elife. 2021. PMID: 33970101 Free PMC article.
-
L-655,708 Does not Prevent Isoflurane-induced Memory Deficits in Old Mice.Transl Neurosci. 2019 Aug 7;10:180-186. doi: 10.1515/tnsci-2019-0032. eCollection 2019. Transl Neurosci. 2019. PMID: 31410301 Free PMC article.
-
Pathophysiological power of improper tonic GABA(A) conductances in mature and immature models.Front Neural Circuits. 2013 Oct 24;7:170. doi: 10.3389/fncir.2013.00170. eCollection 2013. Front Neural Circuits. 2013. PMID: 24167475 Free PMC article. Review.
-
Effects of General Anesthetics on Synaptic Transmission and Plasticity.Curr Neuropharmacol. 2022;20(1):27-54. doi: 10.2174/1570159X19666210803105232. Curr Neuropharmacol. 2022. PMID: 34344292 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous